Pfizer sees revenues double to $81bn thanks to COVID-19 vaccine
- Date: 08-Feb-2022
- Source: SkyNews
- Sector:Economy
- Country:Middle East
Pfizer sees revenues double to $81bn thanks to COVID-19 vaccine
Drugs giant Pfizer has doubled annual sales and profits thanks to its COVID-19 vaccine.
The US firm said revenues rose from $41.7bn in 2020 to $81.3bn last year, largely thanks to the vaccine, known as Comirnaty - which accounted for $36.8bn of the total.
Profits climbed from $9.2bn to $22bn.
Select Sector 
Select Country 
